Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:collaborates_with |
Academic Institutions
|
| gptkbp:focuses_on |
gptkb:Cancer_Immunotherapy
|
| gptkbp:founded |
gptkb:2014
|
| gptkbp:has_part |
gptkb:Research_Institute
|
| gptkbp:headquarters |
gptkb:Netherlands
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aduro Biotech Netherlands
|
| gptkbp:offers |
Therapeutic Products
|
| gptkbp:operates_in |
gptkb:Pharmaceutical_Industry
|
| gptkbp:parent_company |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:receives_funding_from |
Venture Capital Firms
|
| gptkbp:bfsParent |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:bfsLayer |
5
|